{
    "2014-02-11": [
        "Penn's FitzGerald: NSAIDs will confer a risk of hypertension that will relate to the degree of selectivity for COX-2",
        "UPenn's Garrett FitzGerald says PFE's PRECISION trial evaluating safety of Celebrex v. ibuprofen v. naproxen is biased",
        "Important data coming out: Athersys nears end Ph2 in IBD. Partnered with PFE"
    ]
}